MS Pharma Sets Up MENA's First Biologics Manufacturing Hub in Saudi Arabia
MS Pharma has inaugurated the Middle East’s first biologics manufacturing facility in Saudi Arabia, a USD 50 million GMP-approved plant that establishes the company as a regional hub for advanced biopharmaceutical production aligned with Vision 2030.
Biologics Manufacturing Facility | 28/08/2025 | By Mrinmoy Dey | 126
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy